| PERIOD ENDING | 27-Mar-09 | 28-Nov-08 | 29-Aug-08 | 30-May-08 | | Total Revenue | 11,880,000 | 3,682,000 | 13,625,000 | 17,643,000 | | Cost of Revenue | 671,000 | 1,512,000 | 734,000 | (3,438,000) | | | Gross Profit | 11,209,000 | 2,170,000 | 12,891,000 | 21,081,000 | | | Operating Expenses | | Research Development |
-
| 96,000 | 119,000 | 270,000 | | Selling General and Administrative | 5,576,000 | (75,000) | 3,930,000 | 9,538,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 549,000 | 488,000 | 300,000 | 220,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,084,000 | 1,661,000 | 8,542,000 | 11,053,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,084,000 | 1,661,000 | 8,542,000 | 11,053,000 | | Interest Expense | 2,455,000 | 5,260,000 | 7,582,000 | 8,221,000 | | Income Before Tax | 2,629,000 | (3,599,000) | 960,000 | 2,832,000 | | Income Tax Expense | 815,000 | (1,478,000) | 115,000 | 745,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,814,000 | (2,121,000) | 845,000 | 2,087,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,814,000 | (2,121,000) | 845,000 | 2,087,000 | | Preferred Stock And Other Adjustments | (155,000) | (166,000) | (35,000) | (36,000) | | | Net Income Applicable To Common Shares | $1,659,000 | ($2,287,000) | $810,000 | $2,051,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
